Tokyo Tape
Sign in
← Kirin Holdings

Half-year report · Q2

2503.TEDINET S100WHH8
Period2025-01-01 → 2025-06-30
Filed2025-08-08
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥1.14T2025-01-01 → 2025-06-30Cons.Revenue IFRS
Revenue¥2.34T2024-01-01 → 2024-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.10T2024-01-01 → 2024-06-30Cons.Revenue IFRS
Operating income¥68.7bn2025-01-01 → 2025-06-30Cons.Operating profit loss IFRS
Operating income¥80.9bn2024-01-01 → 2024-06-30Cons.Operating profit loss IFRS
Profit before tax¥83.8bn2025-01-01 → 2025-06-30Cons.Profit loss before tax IFRS
Profit before tax¥139.7bn2024-01-01 → 2024-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥108.5bn2024-01-01 → 2024-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥52.8bn2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥58.2bn2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥57.2bn2024-01-01 → 2024-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥60.5bn2025-01-01 → 2025-06-30Cons.Profit loss IFRS
Net income¥74.2bn2024-01-01 → 2024-06-30Cons.Profit loss IFRS
Total assets¥3.30Tat 2025-06-30Cons.Assets IFRS
Total assets¥3.35Tat 2024-12-31Cons.Assets IFRS
Total assets¥3.13Tat 2024-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥1.89Tat 2025-06-30Cons.Liabilities IFRS
Total liabilities¥1.82Tat 2024-12-31Cons.Liabilities IFRS
Net assets / equity¥1.41Tat 2025-06-30Cons.Equity IFRS
Net assets / equity¥1.53Tat 2024-12-31Cons.Equity IFRS
Net assets / equity¥1.59Tat 2024-06-30Cons.Equity IFRS
Net assets / equity¥1.43Tat 2023-12-31vCons.Equity IFRS
Equity (owners)¥1.12Tat 2025-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.18Tat 2024-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.29Tat 2024-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥132.4bnat 2025-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥118.6bnat 2024-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥138.4bnat 2024-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥131.4bnat 2023-12-31vCons.Cash and cash equivalents IFRS
Operating cash flow¥67.3bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥242.8bn2024-01-01 → 2024-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥108.7bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥61.6bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥329.4bn2024-01-01 → 2024-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥116.0bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥35.8bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥58.1bn2024-01-01 → 2024-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥21.6bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥65.232025-01-01 → 2025-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥71.872024-01-01 → 2024-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥70.652024-01-01 → 2024-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥65.222025-01-01 → 2025-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥71.862024-01-01 → 2024-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥70.652024-01-01 → 2024-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio34.0%at 2025-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio35.2%at 2024-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio41.2%at 2024-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-01-01 → 2025-06-30¥47.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-01-01 → 2025-06-30¥14.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2025-01-01 → 2025-06-30¥32.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-01-01 → 2025-06-30−¥591m
Reconciling Itemsreconcilingrevenue2025-01-01 → 2025-06-30−¥38.3bn
Reconciling Itemsreconcilingrevenue intersegment2025-01-01 → 2025-06-30−¥38.3bn
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30−¥30.0bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue2025-01-01 → 2025-06-30¥493.8bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue external2025-01-01 → 2025-06-30¥492.6bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥1.2bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentsegment profit2025-01-01 → 2025-06-30¥53.2bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue2025-01-01 → 2025-06-30¥129.7bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue external2025-01-01 → 2025-06-30¥127.2bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥2.5bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentsegment profit2025-01-01 → 2025-06-30¥8.6bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue2025-01-01 → 2025-06-30¥273.4bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue external2025-01-01 → 2025-06-30¥271.8bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥1.6bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentsegment profit2025-01-01 → 2025-06-30¥29.5bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue2025-01-01 → 2025-06-30¥230.7bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue external2025-01-01 → 2025-06-30¥230.5bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥156m
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentsegment profit2025-01-01 → 2025-06-30¥33.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-01-01 → 2024-06-30¥45.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-01-01 → 2024-06-30¥10.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-01-01 → 2024-06-30¥34.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-06-30−¥331m
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-06-30−¥38.5bn
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-06-30−¥38.5bn
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30−¥26.5bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue2024-01-01 → 2024-06-30¥513.7bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue external2024-01-01 → 2024-06-30¥512.5bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥1.2bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentsegment profit2024-01-01 → 2024-06-30¥50.3bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue2024-01-01 → 2024-06-30¥71.1bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue external2024-01-01 → 2024-06-30¥69.6bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥1.6bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentsegment profit2024-01-01 → 2024-06-30−¥1.6bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue2024-01-01 → 2024-06-30¥271.5bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue external2024-01-01 → 2024-06-30¥270.0bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥1.5bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentsegment profit2024-01-01 → 2024-06-30¥30.1bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue2024-01-01 → 2024-06-30¥233.0bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue external2024-01-01 → 2024-06-30¥232.8bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥132m
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-06-30¥41.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 858
ItemContextValueUnit
Purchase of treasury stock of subsidiaries in consolidation fin cf IFRSCurrentYTDDuration-4000000JPY
Decrease increase in deposits for purchase of treausury shares of subsidiaries fin cf IFRSPrior1YTDDuration-8959000000JPY
Decrease increase in deposits for purchase of treausury shares of subsidiaries fin cf IFRSCurrentYTDDuration－JPY
Dividends paid fin cf IFRSPrior1YTDDuration-29560000000JPY
Dividends paid fin cf IFRSCurrentYTDDuration-28755000000JPY
Dividends paid to non controlling interests fin cf IFRSPrior1YTDDuration-7215000000JPY
Dividends paid to non controlling interests fin cf IFRSCurrentYTDDuration-6988000000JPY
Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRSPrior1YTDDuration－JPY
Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRSCurrentYTDDuration-81605000000JPY
Other fin cf IFRSPrior1YTDDuration-22000000JPY
Other fin cf IFRSCurrentYTDDuration-385000000JPY
Net cash provided by used in financing activities IFRSPrior1YTDDuration-21568000000JPY
Net cash provided by used in financing activities IFRSCurrentYTDDuration35825000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSPrior1YTDDuration35889000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSCurrentYTDDuration-3926000000JPY
Net increase decrease in cash and cash equivalents IFRSPrior1YTDDuration7008000000JPY
Net increase decrease in cash and cash equivalents IFRSCurrentYTDDuration37596000000JPY
Cash and cash equivalents IFRSPrior2YearInstant131399000000JPY
Cash and cash equivalents IFRSPrior1YearInstant118617000000JPY
Effect of changes in accounting policies cce IFRSPrior2YearInstant－JPY
Effect of changes in accounting policies cce IFRSPrior1YearInstant-10731000000JPY
Restated cash and cash equivalents at beginning of period cce IFRSPrior2YearInstant131399000000JPY
Restated cash and cash equivalents at beginning of period cce IFRSPrior1YearInstant107886000000JPY
Net increase decrease in cash and cash equivalents resulting from transfer to assets held for sale IFRSPrior1YTDDuration－JPY
Net increase decrease in cash and cash equivalents resulting from transfer to assets held for sale IFRSCurrentYTDDuration-13074000000JPY
Cash and cash equivalents IFRSPrior1QuarterInstant138406000000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant132408000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E00395-000AlcoholicBeveragesReportableSegmentMember512499000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E00395-000NonAlcoholicBeveragesReportableSegmentMember270044000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E00395-000PharmaceuticalsReportableSegmentMember232842000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E00395-000HealthScienceReportableSegmentMember69564000000JPY
Revenue from external customers IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember10874000000JPY
Revenue from external customers IFRSPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenue from external customers IFRSPrior1YTDDuration1095823000000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00395-000AlcoholicBeveragesReportableSegmentMember1193000000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00395-000NonAlcoholicBeveragesReportableSegmentMember1471000000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00395-000PharmaceuticalsReportableSegmentMember132000000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00395-000HealthScienceReportableSegmentMember1571000000JPY
Intersegment revenue IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember34173000000JPY
Intersegment revenue IFRSPrior1YTDDuration_ReconcilingItemsMember-38540000000JPY
Intersegment revenue IFRSPrior1YTDDuration－JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00395-000AlcoholicBeveragesReportableSegmentMember513692000000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00395-000NonAlcoholicBeveragesReportableSegmentMember271514000000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00395-000PharmaceuticalsReportableSegmentMember232974000000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00395-000HealthScienceReportableSegmentMember71135000000JPY
Revenue IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember45048000000JPY
Revenue IFRSPrior1YTDDuration_ReconcilingItemsMember-38540000000JPY
Revenue IFRSPrior1YTDDuration1095823000000JPY
Segment profit loss IFRSPrior1YTDDuration_jpcrp040300-q2r_E00395-000AlcoholicBeveragesReportableSegmentMember50314000000JPY
Segment profit loss IFRSPrior1YTDDuration_jpcrp040300-q2r_E00395-000NonAlcoholicBeveragesReportableSegmentMember30131000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2024-12-31pass
balance sheet identityconsolidated 2025-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-06-30pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · revenueconsolidated 2024-01-01/2024-06-30pass
statement vs summary · revenueconsolidated 2025-01-01/2025-06-30pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsconsolidated 2025-06-30pass